Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 159

1.

Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data.

Schlaudecker EP, Munoz FM, Bardají A, Boghossian NS, Khalil A, Mousa H, Nesin M, Nisar MI, Pool V, Spiegel HML, Tapia MD, Kochhar S, Black S; Brighton Collaboration Small for Gestational Age Working Group.

Vaccine. 2017 Dec 4;35(48 Pt A):6518-6528. doi: 10.1016/j.vaccine.2017.01.040. No abstract available.

2.

Improving accountability in vaccine decision-making.

Timmis JK, Black S, Rappuoli R.

Expert Rev Vaccines. 2017 Nov;16(11):1057-1066. doi: 10.1080/14760584.2017.1382358. Epub 2017 Oct 9.

PMID:
28929818
3.

Building capacity for active surveillance of vaccine adverse events in the Americas: A hospital-based multi-country network.

Bravo-Alcántara P, Pérez-Vilar S, Molina-León HF, Sturkenboom M, Black S, Zuber PLF, Maure C, Castro JL; L.A.N.V.A.P. (Latin American Network for VAccine Pharmacovigilance).

Vaccine. 2017 Aug 10. pii: S0264-410X(17)30561-3. doi: 10.1016/j.vaccine.2017.04.069. [Epub ahead of print]

PMID:
28803714
4.

Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiative.

Guillard-Maure C, Elango V, Black S, Perez-Vilar S, Castro JL, Bravo-Alcántara P, Molina-León HF, Weibel D, Sturkenboom M, Zuber PLF; WHO Global Vaccine Safety-Multi Country Collaboration.

Vaccine. 2017 Aug 2. pii: S0264-410X(17)31011-3. doi: 10.1016/j.vaccine.2017.07.085. [Epub ahead of print]

PMID:
28780118
5.

Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study.

Petousis-Harris H, Paynter J, Morgan J, Saxton P, McArdle B, Goodyear-Smith F, Black S.

Lancet. 2017 Sep 30;390(10102):1603-1610. doi: 10.1016/S0140-6736(17)31449-6. Epub 2017 Jul 10.

PMID:
28705462
6.

Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination.

Perez-Vilar S, Weibel D, Sturkenboom M, Black S, Maure C, Castro JL, Bravo-Alcántara P, Dodd CN, Romio SA, de Ridder M, Nakato S, Molina-León HF, Elango V, Zuber PLF; WHO Global Vaccine Safety-Multi Country Collaboration.

Vaccine. 2017 May 27. pii: S0264-410X(17)30620-5. doi: 10.1016/j.vaccine.2017.05.012. [Epub ahead of print]

PMID:
28558983
7.

Emerging infectious diseases: A proactive approach.

Bloom DE, Black S, Rappuoli R.

Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4055-4059. doi: 10.1073/pnas.1701410114. Epub 2017 Apr 10.

8.

Herpes Zoster Vaccine and the Medicare Population.

Black S.

Clin Infect Dis. 2017 Mar 15;64(6):794-795. doi: 10.1093/cid/ciw858. No abstract available.

PMID:
28362956
9.

Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy.

Jones CE, Munoz FM, Kochhar S, Vergnano S, Cutland CL, Steinhoff M, Black S, Heininger U, Bonhoeffer J, Heath PT.

Vaccine. 2016 Dec 1;34(49):6007-6014. doi: 10.1016/j.vaccine.2016.07.007. Epub 2016 Oct 25.

10.

Recognizing the Importance of Vaccine Confidence.

Black S.

EBioMedicine. 2016 Oct;12:28-29. doi: 10.1016/j.ebiom.2016.08.048. Epub 2016 Sep 2. No abstract available.

11.

Global alignment of immunization safety assessment in pregnancy - The GAIA project.

Bonhoeffer J, Kochhar S, Hirschfeld S, Heath PT, Jones CE, Bauwens J, Honrado Á, Heininger U, Muñoz FM, Eckert L, Steinhoff M, Black S, Padula M, Sturkenboom M, Buttery J, Pless R, Zuber P; GAIA project participants.

Vaccine. 2016 Dec 1;34(49):5993-5997. doi: 10.1016/j.vaccine.2016.07.006. Epub 2016 Oct 14.

12.

Regulation of Thrombin-Induced Lung Endothelial Cell Barrier Disruption by Protein Kinase C Delta.

Xie L, Chiang ET, Wu X, Kelly GT, Kanteti P, Singleton PA, Camp SM, Zhou T, Dudek SM, Natarajan V, Wang T, Black SM, Garcia JG, Jacobson JR.

PLoS One. 2016 Jul 21;11(7):e0158865. doi: 10.1371/journal.pone.0158865. eCollection 2016.

13.

The Safety of PsA-TT in Pregnancy: An Assessment Performed Within the Navrongo Health and Demographic Surveillance Site in Ghana.

Wak G, Williams J, Oduro A, Maure C, Zuber PL, Black S.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S489-92. doi: 10.1093/cid/civ625.

14.

Influence of Statins on Influenza Vaccine Response in Elderly Individuals.

Black S, Nicolay U, Del Giudice G, Rappuoli R.

J Infect Dis. 2016 Apr 15;213(8):1224-8. doi: 10.1093/infdis/jiv456. Epub 2015 Oct 28.

PMID:
26516142
15.

Gastrulation occurs in multiple phases at two distinct sites in Latrodectus and Cheiracanthium spiders.

Edgar A, Bates C, Larkin K, Black S.

Evodevo. 2015 Oct 21;6:33. doi: 10.1186/s13227-015-0029-z. eCollection 2015.

16.

The costs and effectiveness of large Phase III pre-licensure vaccine clinical trials.

Black S.

Expert Rev Vaccines. 2015;14(12):1543-8. doi: 10.1586/14760584.2015.1091733. Epub 2015 Sep 28. Review.

PMID:
26414015
17.

Prevention and control of meningococcal outbreaks: The emerging role of serogroup B meningococcal vaccines.

Oviedo-Orta E, Ahmed S, Rappuoli R, Black S.

Vaccine. 2015 Jul 17;33(31):3628-35. doi: 10.1016/j.vaccine.2015.06.046. Epub 2015 Jun 17. Review.

PMID:
26093201
18.

Safety and effectiveness of MF-59 adjuvanted influenza vaccines in children and adults.

Black S.

Vaccine. 2015 Jun 8;33 Suppl 2:B3-5. doi: 10.1016/j.vaccine.2014.11.062. Review.

19.

Determinants of maternal immunization in developing countries.

Pathirana J, Nkambule J, Black S.

Vaccine. 2015 Jun 12;33(26):2971-7. doi: 10.1016/j.vaccine.2015.04.070. Epub 2015 Apr 30.

PMID:
25936666
20.

Developing vaccines for an aging population.

Black S, De Gregorio E, Rappuoli R.

Sci Transl Med. 2015 Apr 1;7(281):281ps8. doi: 10.1126/scitranslmed.aaa0722. Review.

PMID:
25834107

Supplemental Content

Loading ...
Support Center